A study investigating the efficacy of our FDA-cleared (human use) pulsed-shortwave-therapy (PSWT) device in initiating a systemic anti-inflammatory response to improve the functionality of canines diagnosed with osteoarthritis. 96% of the treatment group showed either increased passive range of motion, improved behavioral changes, or both compared to 4% for the placebo group. It was published today online in "Veterinary Medicine and Science." Medical professionals can contact us at info@bielcorp.com or 866-757-2284 to request sample products.

https://lnkd.in/eq5hyD3c

#caninearthritismanagement #osteoarthritis #osteoarthritistreatment #veterinarymedicine #veterinarycare #seniordogs #caninearthritis

Pulsed shortwave electromagnetic field therapy increases quality of life in canines with symptoms of osteoarthritics
onlinelibrary.wiley.com

https://www.linkedin.com/feed/update/activity...9792514050